ArticleMolecular oncology2019

In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53.

Jolien Van den Bossche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.